药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Quinethazone
Quinoline Yellow WS
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Quinoline Yellow WS.
Quinethazone
Quinaprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Quinaprilat.
Quinethazone
Perindoprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Perindoprilat.
Quinethazone
Moexiprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Moexiprilat.
Quinethazone
Trandolaprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Trandolaprilat.
Quinethazone
Ramiprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Ramiprilat.
Quinethazone
Fosinoprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Fosinoprilat.
Quinethazone
Benazeprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Benazeprilat.
Quinethazone
Delapril
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Delapril.
Quinethazone
Zofenopril
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Zofenopril.
Quinethazone
Imidapril
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Imidapril.
Quinethazone
Enalaprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Enalaprilat.
Quinethazone
Naxitamab
Naxitamab may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Selpercatinib
Selpercatinib may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Terguride
Terguride may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Dihydroergocryptine
Dihydroergocryptine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Dihydroergocristine
Dihydroergocristine may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Levosalbutamol
Levosalbutamol may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Siponimod
Siponimod may decrease the antihypertensive activities of Aliskiren.
Quinethazone
Propiverine
Propiverine may decrease the antihypertensive activities of Aliskiren.